Bipartisan Michigan lawmakers unveil a bill subjecting US-China biotech deals to outbound investment screening, citing national security risks.
Rep. John Moolenaar (R-MI) (Lenin Nolly/Sipa USA/Sipa via AP Images)
June 2, 2026 08:00 AM EDT
DealsChinaPharmaFDA+
Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech
Max Bayer
US lawmakers reveal policy to curb collaboration with Chinese biotech - Pharmaceutical Technology
美国两党议员推动立法，限制对华生物技术投资
House bill aims to crack down on China biotech deals
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
美两党众议员推出法案，拟禁止威胁国家安全的中国机器人
美众议员跨党推出法案，拟暂禁与中共有关联的公司在SEC注册
美议员推《保护美国免受中国汽车侵害法案》 并要求加强审查中国制医疗设备
The next tech war? Why biotech may become a new US-China battleground
If enacted, BINSA would give lawmakers the right to monitor and restrict American companies from signing biotech and…
Chinese pharma companies are still striking global deals, but rising regulatory pressure is forcing buyers and sellers to rethink…
They're laying the groundwork for legislation and regulation to counter Chinese biopharma companies.
Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic…
美国国会两党议员星期二(6月2日)联合提出一项立法，旨在防止美国制药和生物技术领域的投资流向中国企业。提出该项立法的国会议员表示，此举对于保护美国的药品供应链和研发基础、防范外国对手渗透至关重要。
A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S.…
